Credit Suisse’s Viridian Therapeutics VRDN Stock Holding History

Credit Suisse’s Portfolio VRDN Stock Details VRDN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$838K	Buy
2023 Q4	$894K	Buy
2023 Q3	$613K	Sell
2023 Q2	$1.17M	Buy
2023 Q1	$657K	Buy
2022 Q4	$702K	Sell
2022 Q3	$512K	Buy
2022 Q2	$206K	Buy
2017 Q4	–	Sell
2017 Q3	$95K	Buy